RNA 内幕交易
RNA 的 SEC Form 4 内幕交易记录
总交易
55
买入
0
买入总额
-
卖出总额
$4.2M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(35) | BOYCE SARAH | President and CEO | 卖出 | 7,993 | $72.45 | $579K | 2026-01-21 | CEO卖出, 董事卖出 |
| ★★★★★(35) | BOYCE SARAH | President and CEO | 卖出 | 8,576 | $72.23 | $619K | 2026-01-07 | CEO卖出, 董事卖出 |
| ★★★★★(30) | BOYCE SARAH | President and CEO | 卖出 | 6,394 | $72.45 | $463K | 2026-01-21 | CEO卖出, 董事卖出 |
| ★★★★★(18) | MACLEAN MICHAEL F | Chief Financial Officer | 卖出 | 1,807 | $72.45 | $131K | 2026-01-21 | CFO卖出 |
| ★★★★★(18) | MACLEAN MICHAEL F | Chief Financial Officer | 卖出 | 2,735 | $72.45 | $198K | 2026-01-21 | CFO卖出 |
| ★★★★★(18) | MACLEAN MICHAEL F | Chief Financial Officer | 卖出 | 1,974 | $72.23 | $143K | 2026-01-07 | CFO卖出 |
| ★★★★★(10) | LEVIN ARTHUR A | - | 卖出 | 1,758 | $72.45 | $127K | 2026-01-21 | 董事卖出 |
| ★★★★★(8) | MCCARTHY TERESA | Chief Human Resources Officer | 卖出 | 1,476 | $72.45 | $107K | 2026-01-21 | 高管卖出 |
| ★★★★★(8) | MCCARTHY TERESA | Chief Human Resources Officer | 卖出 | 1,453 | $72.45 | $105K | 2026-01-21 | 高管卖出 |
| ★★★★★(8) | FLANAGAN W. MICHAEL | Chief Scientific Officer | 卖出 | 3,976 | $72.45 | $288K | 2026-01-21 | 高管卖出 |
| ★★★★★(8) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 2,017 | $72.45 | $146K | 2026-01-21 | 高管卖出 |
| ★★★★★(8) | FLANAGAN W. MICHAEL | Chief Scientific Officer | 卖出 | 2,558 | $72.45 | $185K | 2026-01-21 | 高管卖出 |
| ★★★★★(8) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 2,878 | $72.45 | $209K | 2026-01-21 | 高管卖出 |
| ★★★★★(8) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 2,373 | $72.23 | $171K | 2026-01-07 | 高管卖出 |
| ★★★★★(8) | MORIARTY JOHN B | Chief Legal Officer | 卖出 | 2,374 | $72.23 | $171K | 2026-01-07 | 高管卖出 |
| ★★★★★(8) | MCCARTHY TERESA | Chief Human Resources Officer | 卖出 | 1,965 | $72.23 | $142K | 2026-01-07 | 高管卖出 |
| ★★★★★(8) | CALDERARO CHARLES III | Chief Technical Officer | 卖出 | 3,727 | $72.23 | $269K | 2026-01-07 | 高管卖出 |
| ★★★★★(8) | FLANAGAN W. MICHAEL | Chief Scientific Officer | 卖出 | 2,373 | $72.23 | $171K | 2026-01-07 | 高管卖出 |
| ★★★★★(0) | BOYCE SARAH | - | 卖出 | 126,418 | $8.95 | $1.1M | 2026-09-18 | |
| ★★★★★(0) | WINSLOW BRENDAN R. | Chief Financial Officer | 卖出 | 6,742 | $8.95 | $60K | 2026-09-18 | |
| ★★★★★(0) | HOYOS ROCIO MARTIN | Chief Strategy Officer | 卖出 | 8,320 | $8.95 | $74K | 2026-09-18 | |
| ★★★★★(0) | KENNEY STEPHANIE | Chief Corporate Affairs Officer | 卖出 | 2,375 | $8.95 | $21K | 2026-09-18 | |
| ★★★★★(0) | YOUNIS HUSAM | Chief Scientific Officer | 卖出 | 11,216 | $8.95 | $100K | 2026-09-18 | |
| ★★★★★(0) | GALLAGHER KATHLEEN P. | Chief Executive Officer and President | 卖出 | 11,632 | $8.95 | $104K | 2026-09-18 | |
| ★★★★★(0) | FLANAGAN W. MICHAEL | - | 卖出 | 22,812 | $8.95 | $204K | 2026-09-18 | |
| ★★★★★(0) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 21,459 | $8.95 | $192K | 2026-09-18 | |
| ★★★★★(0) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 30,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | YOUNIS HUSAM | Chief Scientific Officer | 卖出 | 30,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | WINSLOW BRENDAN R. | Chief Financial Officer | 卖出 | 60,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | HOYOS ROCIO MARTIN | Chief Strategy Officer | 卖出 | 60,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | WINSLOW BRENDAN R. | Chief Financial Officer | 卖出 | 30,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | YOUNIS HUSAM | Chief Scientific Officer | 卖出 | 60,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | KENNEY STEPHANIE | Chief Corporate Affairs Officer | 卖出 | 60,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 60,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | KENNEY STEPHANIE | Chief Corporate Affairs Officer | 卖出 | 30,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | HOYOS ROCIO MARTIN | Chief Strategy Officer | 卖出 | 30,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | GALLAGHER KATHLEEN P. | Chief Executive Officer and President | 卖出 | 205,000 | - | - | 2026-04-20 | |
| ★★★★★(0) | GALLAGHER KATHLEEN P. | Chief Executive Officer and President | 卖出 | 102,500 | - | - | 2026-04-20 | |
| ★★★★★(0) | BOYCE SARAH | - | 卖出 | 20,000 | - | - | 2026-02-27 | |
| ★★★★★(0) | BOESS CARSTEN | - | 卖出 | 20,000 | - | - | 2026-02-27 | |
| ★★★★★(0) | FLANAGAN W. MICHAEL | - | 卖出 | 20,000 | - | - | 2026-02-27 | |
| ★★★★★(0) | WILSON TROY EDWARD | - | 卖出 | 20,000 | - | - | 2026-02-27 | |
| ★★★★★(0) | SKERJANEC SIMONA | - | 卖出 | 20,000 | - | - | 2026-02-27 | |
| ★★★★★(0) | HOYOS ROCIO MARTIN | Chief Strategy Officer | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | FLANAGAN W. MICHAEL | - | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | WILSON TROY EDWARD | - | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | GALLAGHER KATHLEEN P. | Chief Executive Officer and President Exhibit List - Exhibit 24.1 Power of Attorney | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | KENNEY STEPHANIE | Chief Corporate Affairs Officer Exhibit List - Exhibit 24.1 Power of Attorney | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | YOUNIS HUSAM | Chief Scientific Officer | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | HUGHES STEVEN GEORGE | Chief Medical Officer | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | BOYCE SARAH | - | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | SKERJANEC SIMONA | - | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | WINSLOW BRENDAN R. | Chief Financial Officer | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | BOESS CARSTEN | - | 卖出 | 0 | - | - | 2026-02-26 | |
| ★★★★★(0) | LEVIN ARTHUR A | - | 卖出 | 0 | - | - | 2026-01-21 |